Data as of Jul 23
| +0.57 / +2.83%|
The 7 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 33.00, with a high estimate of 42.00 and a low estimate of 24.00. The median estimate represents a +59.19% increase from the last price of 20.73.
The current consensus among 7 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.